Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
4.250
-0.050 (-1.16%)
Nov 28, 2025, 4:00 PM EST - Market closed
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $143.04 million as of November 28, 2025. Its market cap has increased by 202.33% in one year.
Market Cap
143.04M
Enterprise Value
129.54M
1-Year Change
202.33%
Ranking
Category
Stock Price
$4.25
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $143.04M, an increase of 117.58%. That is a compound annual growth rate of 21.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 142.71M | 135.81% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |